CIK: 914208
Ticker: IVZ
Exchange: NYSE
Invesco Ltd.
Total: $540,896,546,112
Street: 1331 Spring Street NW
, Suite 2500
City: Atlanta
State: GA
Information for Viewing 13F Reports:
- Name: The name of the company.
- CUSIP: A unique 9-character alphanumeric code that identifies a specific stock or security in the U.S.
- Class: The investment company’s series name. A registered investment company may have multiple series, each with a separate securities portfolio.
- Value: The monetary value of the holdings in USD.
- Shares: The number of shares held.
- Share Price: The price of shares at the time of filing.
- Investment: The type of investment.
- % of Portfolio: The percentage that this position represents in the total portfolio.
| Quarter | Period of Report | Holdings | Value | Type | Filling Date | Filling ID |
|---|---|---|---|---|---|---|
| Q2 25 | 30-Jun-2025 | 24840 | $587,990,232,435 | 13F-HR | 13-Aug-2025 | 0000914208-25-000341 |
| Q1 25 | 31-Mar-2025 | 24094 | $527,931,241,189 | 13F-HR | 12-May-2025 | 0000914208-25-000230 |
| Q4 24 | 31-Dec-2024 | 24226 | $540,896,546,112 | 13F-HR | 13-Feb-2025 | 0000914208-25-000103 |
| Q3 24 | 30-Sep-2024 | 24754 | $517,950,029,214 | 13F-HR | 12-Nov-2024 | 0000914208-24-000547 |
| Q2 24 | 30-Jun-2024 | 23132 | $472,838,168,182 | 13F-HR | 13-Aug-2024 | 0000914208-24-000380 |
| Q1 24 | 31-Mar-2024 | 22970 | $465,561,089,341 | 13F-HR | 14-May-2024 | 0000914208-24-000311 |
| Q4 23 | 31-Dec-2023 | 22913 | $420,237,004,974 | 13F-HR | 13-Feb-2024 | 0000914208-24-000213 |
| Q3 23 | 30-Sep-2023 | 22531 | $371,300,617,662 | 13F-HR | 13-Nov-2023 | 0000914208-23-000534 |
| Q2 23 | 30-Jun-2023 | 21562 | $381,450,019,562 | 13F-HR | 11-Aug-2023 | 0000914208-23-000438 |
| Q1 23 | 31-Mar-2023 | 22018 | $358,483,206,237 | 13F-HR | 12-May-2023 | 0000914208-23-000391 |
| Q4 22 | 31-Dec-2022 | 22543 | $341,419,125,921 | 13F-HR | 13-Feb-2023 | 0000914208-23-000284 |
| Q3 22 | 30-Sep-2022 | 22479 | $310,689,376,000 | 13F-HR | 14-Nov-2022 | 0000914208-22-000532 |
| Q2 22 | 30-Jun-2022 | 22641 | $330,037,972,000 | 13F-HR | 15-Aug-2022 | 0000914208-22-000479 |
| Q1 22 | 31-Mar-2022 | 21680 | $392,052,274,000 | 13F-HR | 16-May-2022 | 0000914208-22-000379 |
| Q4 21 | 31-Dec-2021 | 20586 | $414,838,594,000 | 13F-HR | 14-Feb-2022 | 0000914208-22-000313 |
| Q3 21 | 30-Sep-2021 | 20343 | $394,591,636,000 | 13F-HR | 15-Nov-2021 | 0000914208-21-000585 |
| Q2 21 | 30-Jun-2021 | 19532 | $406,582,151,000 | 13F-HR | 17-Aug-2021 | 0000914208-21-000482 |
| Q1 21 | 31-Mar-2021 | 15606 | $374,713,493,000 | 13F-HR | 17-May-2021 | 0000914208-21-000429 |
| Q4 20 | 31-Dec-2020 | 16096 | $343,588,172,000 | 13F-HR | 16-Feb-2021 | 0000914208-21-000251 |
| Q3 20 | 30-Sep-2020 | 16127 | $295,819,562,000 | 13F-HR | 16-Nov-2020 | 0000914208-20-000486 |
| Q2 20 | 30-Jun-2020 | 16198 | $279,683,425,000 | 13F-HR | 14-Aug-2020 | 0000914208-20-000401 |
| Q1 20 | 31-Mar-2020 | 15949 | $237,579,403,000 | 13F-HR | 15-May-2020 | 0000914208-20-000332 |
| Q4 19 | 31-Dec-2019 | 13428 | $322,077,743,000 | 13F-HR | 14-Feb-2020 | 0000914208-20-000233 |
| Q3 19 | 30-Sep-2019 | 12530 | $382,355,947,000 | 13F-HR | 14-Nov-2019 | 0000914208-19-000451 |
| Q2 19 | 30-Jun-2019 | 12289 | $419,132,888,000 | 13F-HR | 14-Aug-2019 | 0000914208-19-000375 |
| Q2 19 | 30-Jun-2019 | 12286 | $388,534,051,000 | 13F-HR/A | 14-Aug-2019 | 0000914208-19-000377 |
| Q1 19 | 31-Mar-2019 | 11924 | $296,531,641,000 | 13F-HR | 15-May-2019 | 0000914208-19-000256 |
| Q4 18 | 31-Dec-2018 | 13243 | $261,243,090,000 | 13F-HR | 14-Feb-2019 | 0000914208-19-000182 |
| Q3 18 | 30-Sep-2018 | 13326 | $317,786,216,000 | 13F-HR | 14-Nov-2018 | 0000914208-18-000432 |
| Q2 18 | 30-Jun-2018 | 13590 | $302,145,795,000 | 13F-HR | 14-Aug-2018 | 0000914208-18-000380 |
| Q1 18 | 31-Mar-2018 | 13232 | $267,555,240,000 | 13F-HR | 15-May-2018 | 0000914208-18-000321 |
| Q4 17 | 31-Dec-2017 | 13192 | $277,307,818,000 | 13F-HR | 14-Feb-2018 | 0000914208-18-000216 |